Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bevan

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Biosensors & Bioelectronics|April 16, 2025
Handheld ISFET Lab-on-Chip detection of YAP1 nucleic acid and AR-FL and AR-V7 mRNA from liquid biopsies for prostate cancer prognosisJoseph Broomfield, Melpomeni Kalofonou, Costanza Gulli, et al.
Nature Communications|July 2, 2021
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cellsD A Leach, A Mohr, E S Giotis, et al.
Nature Communications|December 4, 2019
Seawater softening of suture zones inhibits fracture propagation in Antarctic ice shelvesBernd Kulessa, Adam D Booth, Martin O'Leary, et al.
Oncogene|September 12, 2006
Prohibitin, a protein downregulated by androgens, represses androgen receptor activityS C Gamble, D Chotai, M Odontiadis, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 16, 2021
Follicle-stimulating hormone promotes growth of human prostate cancer cell line-derived tumor xenograftsOlayiwola O Oduwole, Ariel Poliandri, Anthony Okolo, et al.
International Journal of Obesity (2005)|July 18, 2020
High fat diet causes distinct aberrations in the testicular proteomeS Jarvis, L A Gethings, L Samanta, et al.
Molecular Endocrinology (Baltimore, Md.)|August 18, 2012
Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancerVikash Reebye, Laia Querol Cano, Derek N Lavery, et al.
Endocrine Oncology (Bristol, England)|July 11, 2025
Thieno[2,3-<i>b</i>]pyridine compounds potently inhibit prostate cancer growth and motilityM A Alkheilewi, D A Leach, A Mohr, et al.
The Journal of Endocrinology|January 9, 2023
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancerJ N Zamarbide Losada, E Sulpice, S Combe, et al.
Molecular & Cellular Proteomics : MCP|February 20, 2015
Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cellsGreg N Brooke, Simon C Gamble, Michael A Hough, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Biosensors & Bioelectronics|April 16, 2025
Handheld ISFET Lab-on-Chip detection of YAP1 nucleic acid and AR-FL and AR-V7 mRNA from liquid biopsies for prostate cancer prognosisJoseph Broomfield, Melpomeni Kalofonou, Costanza Gulli, et al.
Nature Communications|July 2, 2021
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cellsD A Leach, A Mohr, E S Giotis, et al.
Nature Communications|December 4, 2019
Seawater softening of suture zones inhibits fracture propagation in Antarctic ice shelvesBernd Kulessa, Adam D Booth, Martin O'Leary, et al.
Oncogene|September 12, 2006
Prohibitin, a protein downregulated by androgens, represses androgen receptor activityS C Gamble, D Chotai, M Odontiadis, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 16, 2021
Follicle-stimulating hormone promotes growth of human prostate cancer cell line-derived tumor xenograftsOlayiwola O Oduwole, Ariel Poliandri, Anthony Okolo, et al.
International Journal of Obesity (2005)|July 18, 2020
High fat diet causes distinct aberrations in the testicular proteomeS Jarvis, L A Gethings, L Samanta, et al.
Molecular Endocrinology (Baltimore, Md.)|August 18, 2012
Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancerVikash Reebye, Laia Querol Cano, Derek N Lavery, et al.
Endocrine Oncology (Bristol, England)|July 11, 2025
Thieno[2,3-<i>b</i>]pyridine compounds potently inhibit prostate cancer growth and motilityM A Alkheilewi, D A Leach, A Mohr, et al.
The Journal of Endocrinology|January 9, 2023
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancerJ N Zamarbide Losada, E Sulpice, S Combe, et al.
Molecular & Cellular Proteomics : MCP|February 20, 2015
Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cellsGreg N Brooke, Simon C Gamble, Michael A Hough, et al.
Pageof 14